Cogent Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€992.71K - Gross profit
-€992.71K - SG&A expenses
€41.85M - R&D expenses
€214.27M - EBITDA
-€251.22M - D&A
€3.90M - EBIT
-€257.11M - Interest expenses
€269.41K - EBT
-€243.74M - Tax expenses
€0.00 - Net income
-€243.74M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€202.49K - Changes in working capital
€13.20M - Operating cash flow
-€200.44M - Capex
€886.31K - Other investing cash flow
€0.00 - Net investing cash flow
€171.73M - Total cash dividends paid
€0.00 - Issuance of common stock
€20.72M - Debt repayment
€40.52M - Other financing cash flow
€1.18M - Net financing cash flow
€62.50M - Foreign exchange effects
€0.00 - Net change in cash
€33.79M - Cash at end of period
€109.48M - Free cash flow
-€199.55M
Balance sheet
- Cash and cash equivalents
€109.48M - Cash and short-term investments
€204.07M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€6.14M - Total current assets
€210.22M - Property, plant & equipment
€21.40M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€4.17M - Total non-current assets
€25.58M - Total assets
€235.79M - Accounts payable
€14.26M - Short-term debt
€1.42M - Other current liabilities
€34.44M - Total current liabilities
€50.13M - Long-term debt
€50.62M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€2.02M - Total non-current liabilities
€52.65M - Total liabilities
€102.77M - Common stock
€97.81K - Retained earnings
-€862.29M - Other equity
€11.15K - Total equity
€133.02M - Total liabilities and shareholders' equity
€235.79M
Company information
- Market capitalization
€689.51M - Employees
205 - Enterprise Value
€717.68M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-183.2% Much worse than peer group: -24.3% - ROA
-
-103.4% Much worse than peer group: -72.4% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-29.2% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.19M